A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

The dual role of autophagy in cancer




TekijätEskelinen EL

KustantajaELSEVIER SCI LTD

Julkaisuvuosi2011

JournalCurrent Opinion in Pharmacology

Tietokannassa oleva lehden nimiCURRENT OPINION IN PHARMACOLOGY

Lehden akronyymiCURR OPIN PHARMACOL

Vuosikerta11

Numero4

Aloitussivu294

Lopetussivu300

Sivujen määrä7

ISSN1471-4892

DOIhttps://doi.org/10.1016/j.coph.2011.03.009


Tiivistelmä
Autophagy is a mechanism for the degradation of cytoplasmic material, damaged organelles and aggregate-prone proteins in lysosomes. Recent evidence indicates that autophagy is a tumor suppressor mechanism, which is connected to its role in the clearance of the scaffold protein p62/SQSTM1 and prevention of oxidative stress and genomic instability. However, since autophagy is a survival mechanism, cancer cells can also exploit it to survive nutrient limitation and hypoxia that often occur in solid tumors. Tumor cells can also upregulate autophagy as a response to cancer treatment, and recent studies show that inhibition of autophagy can enhance the killing of tumor cells after treatment. Interestingly, the FK506-binding protein 51 plays a role in the autophagy-linked radiation resistance of malignant melanoma.



Last updated on 2024-26-11 at 22:56